Suven Life Sciences' Q4 net loss widens over 65 pc as revenue falls 39 pc
Mumbai, May 13 (IANS) Homegrown biopharma major Suven Life Sciences on Tuesday reported over 65 per cent increase in its net loss for the fourth quarter (Q4) of FY25, as a significant drop in revenue weighed heavily on its financial performance.